Condition: Myelofibrosis · Sponsor: Takeda
The main aim of this study is to learn how safe elritercept is and how well it is tolerated when taken alone and in combination with the JAK inhibitor, ruxolitinib. Other aims are to learn about the effects of elritercept on the signs and symptoms of MF when taken with or without ruxolitinib and to learn how elritercept affects the body, how the body processes elritercept, and the effects of elritercept on anemia when taken with or without ruxolitinib The study will also check on how safe elritercept is and how well it is tolerated.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| Concord Hospital | Concord, New South Wales, Australia | Recruiting |
| The Tweed Hospital | Tweed Heads, New South Wales, Australia | Recruiting |
| Flinders Medical Centre | Woodville South, South Australia, Australia | Recruiting |
| St. Vincents Hospital Melbourne | Fitzroy, Victoria, Australia | Recruiting |
| Royal Melbourne Hospital | Melbourne, Victoria, Australia | Recruiting |
| Ballarat Oncology & Haematology Service | Wendouree, Victoria, Australia | Recruiting |
| Hospital de Clinicas de Porto Alegre | Porto Alegre, Brazil | Recruiting |
| IMV-Pesquisa Cardiologica Sociedade Simples | Porto Alegre, Brazil | Recruiting |
| Albert Einstein Sociedade Beneficente Israelita Brasiliera | São Paulo, Brazil | Recruiting |
| Hospital Beneficencia Portuguesa de Sao Paulo | São Paulo, Brazil | Recruiting |
| Hospital Das Clinicas Da Faculdade de Medicina Da U S P | São Paulo, Brazil | Recruiting |
| Instituto de Ensino e Pesquisas Sao Lucas | São Paulo, Brazil | Recruiting |
+ 34 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05037760